Effects of Imidazoline Derivative RX871024 on Insulin, Glucagon, and Somatostatin Secretion from Isolated Perfused Rat Pancreas
- 9 November 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 252 (1) , 162-165
- https://doi.org/10.1006/bbrc.1998.9635
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- RIN14B: a pancreatic δ‐cell line that maintains functional ATP‐dependent K+ channels and capability to secrete insulin under conditions where it no longer secretes somatostatinFEBS Letters, 1997
- Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreasMetabolism, 1996
- A stable peroxovanadium compound with insulin-like action in human fat cellsDiabetologia, 1996
- The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1‐ and I2‐sitesBritish Journal of Pharmacology, 1994
- Sulphonylurea (Glibenclamide) enhances somatostatin and inhibits glucagon release induced by arginineActa Physiologica Scandinavica, 1980
- Hyperglucagonemia and Its SuppressionNew England Journal of Medicine, 1978
- Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.Journal of Clinical Investigation, 1977
- The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.Journal of Clinical Investigation, 1976
- Effect of phentolamine and preperfusion with glucose on insulin release from the isolated perfused pancreas from fasted and fed ratsDiabetologia, 1975
- Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamideDiabetologia, 1969